New routes towards azomethine ylide generation from prolines to synthesize diverse N-heterocycles: a DFT supported endo-selective mechanism

Radha M. Laha ab, Shobhon Aicha, Ankan Kumar Sarkarc, Tanmoy Duttad, Narendra Nath Ghoshe, Saikat Khamarui*f and Dilip K. Maiti*a
aDepartment of Chemistry, University of Calcutta, 92 A. P. C. Road, Kolkata-700009, India. E-mail: dkmchem@caluniv.ac.in
bDepartment of Science & Humanities, Murshidabad Institute of Technology, West Bengal-742102, India
cSchool of Material Science, Indian Association for the Cultivation of Science, Jadavpur, Kolkata-700032, India
dDepartment of Chemistry, JIS College of Engineering, Kalyani, West Bengal 741235, India
eDepartment of Chemistry, Pakuahat A.N.M. High School, Malda, West Bengal 732138, India
fDepartment of Chemistry, Government General Degree College at Kalna-1, Purba Bardhhaman, 713405, India. E-mail: saikatkhamarui21@gmail.com

Received 28th June 2024 , Accepted 14th August 2024

First published on 14th August 2024


Abstract

Azomethine ylides are generated using either organocatalysts or metal catalysts via a ballet of decarboxylative C–N coupling choreographed by prolines. These strategies enable diastereoselective [3 + 2] cycloaddition, C–C coupling, and ring annulation, providing sustainable routes. The synthesized pyrrolizines and other heterocycles have potential applications in the development of crucial biomolecules and pharmaceuticals. The endoselectivity of the azomethine ylide is realized and supported through DFT calculations.


Introduction

The catalytic asymmetric 1,3-dipolar cycloaddition of azomethine ylides with activated olefins has emerged as a highly valuable and firmly established approach for preparing enantio-enriched substituted N-heterocycles such as pyrrolidines and pyrrolizines.1,2 Pyrrolidines are important bioactive scaffolds3 with medicinal properties, including HIV inhibition and antifungal, antibacterial, and antithrombotic activities.4–6 Structurally diverse pyrrolizine derivatives are found in many natural products and exhibit a range of bioactivities, making them attractive to chemists.7 Building upon the earlier work of Grigg and colleagues,8 who employed stoichiometric amounts of metal salts and an ephedrine derivative as a chiral ligand, the research groups of Zhang9 (utilizing a chiral Ag complex) and Jørgensen10 (employing a Zn-based chiral Lewis acid) independently reported the initial instances of catalytic enantioselective 1,3-dipolar cycloaddition using azomethine ylides derived from imino-esters and activated olefins. This process's remarkable efficacy relies on the generation of a metalated azomethine ylide through the coordination of the nitrogen and oxygen atoms to the metal. The decarboxylative generation of azomethine ylides from amino acids and carbonyl compounds has been extensively investigated by Rizzi11 and others,12 including reports utilizing copper catalysts13 and NHC-gold(I) complexes.14 Recently, we presented the formation of stable azomethine ylides from L-proline and phenyl glyoxal, followed by their 1,3-dipolar cycloaddition to produce fused N-heterocycles.15 Li et al. and others reported the copper-catalyzed oxidative synthesis of azomethine ylides from L-prolines and aldehydes, alcohols, or benzyl halides.16

We now aim to broaden the scope of azomethine ylide formation by using L-proline and β-nitrostyrene with benzylamine as an organocatalyst and achieving redox neutrality and accessibility. Herein, we present our preliminary findings on the benzylamine-catalyzed generation of azomethine ylides using proline and β-nitrostyrene (eqn (iii), Scheme 1) as well as another protocol involving proline and benzylamine as substrates (eqn (iv), Scheme 1). This reactive intermediate (1,3-dipole) has been captured using common organic techniques, including intermolecular [3 + 2]-cycloaddition reactions with electron-deficient alkenes, C–C coupling with alkynes, and ring annulation reactions to form valuable fused N-heterocycles. Through this regio- and stereo-selective pathway, several new bonds and chiral centers have been formed, highlighting the significance of the decarboxylative C–C and C–N coupling reactions as powerful synthetic tools due to their efficiency, selectivity, and convenience.


image file: d4ob01004c-s1.tif
Scheme 1 Traditional vs. new strategies for azomethine ylide generation.

Results and discussion

Our investigation began with the reaction involving L-proline (1a, 1 mmol) and β-nitrostyrene (3a, 1 mmol) and a catalytic amount of CuBr (5 mol%) in toluene under reflux conditions. Initially, no product (6a) was obtained (Table 1, entries 1 and 2 and Scheme 2).
image file: d4ob01004c-s2.tif
Scheme 2 Development and trapping of azomethine ylide via organocatalytic coupling path.
Table 1 Optimisation of the developed C–N and C–C coupling reactions via a common intermediate azomethine ylide
Entry Catalysta Solventc Scheme 2 Scheme 3
Time (h) 6a, yieldd (%) Time (h) 7a, yieldd (%)
a 5 mol%.b 10 mol%.c 5 mL.d Yield of the isolated product after column chromatography.e Not detected.f 130 °C for toluene.g Reflux. Bold indicates maximum yield in this series and hence highlights the optimum reaction condition.
1 CuBr Toluenef 10 nde 10 65
2 CuI Toluene 10 nd 10 60
3 AuCl Toluene 24 nd 24 10
4 Ag(OTf)2 Toluene 24 nd 24 15
5 Ir(cod)Cl Toluene 24 nd 24 nde
6 FeCl3 Toluene 24 nd 24 nd
7 CuBr MeCNg 24 nd 24 24
8 CuBr THFf 24 nd 24 25
9 CuBr CH2Cl2 24 nd 24 nd
10 Toluene 24 nd 24 nd
11 2a CH2Cl2 24 15
12 2ab Toluene 8 68
13 2a THF 24 25
14 (S)-(−)-1-Phenylethylamine Toluene 12 40
15 Et3N Toluene 24 10


To enhance the yield, we employed various metal catalysts such as AuCl, AgOTf, Ir(cod)Cl, and FeCl3 (entries 3–6, Scheme 2); unfortunately, none of them afforded 6a. Interestingly, when 1.0 equiv. of L-proline (1a), 0.1 equiv. of benzyl amine (2a), and 2.0 equiv. of β-nitrostyrene (3a) were heated in toluene at 130 °C, we exclusively obtained 6a without the presence of any metal salt (entry 12, Scheme 2). Moreover, we observed that the absence of 2a during the reaction (Table 1, entry 10 and Scheme 2) prevented the formation of 6a. The use of (S)-(−)-1-phenylethylamine, a chiral base, did not impact the yield and chiral induction of product 6a (entry 14, Table 1 and Scheme 2). Using a strong base like triethylamine instead of 2a did not improve the yield of 6a (entry 15, Table 1 and Scheme 2).

In another experiment, when 1a and 2a were employed with phenyl acetylene (4a), surprisingly, we achieved a good yield of 7a (65%) with CuBr (Table 1, entry 1 and Scheme 3) compared with other metal salts (entries 2–6, Scheme 3) under aerobic conditions. Without a metal catalyst, no conversion was found (entry 10, Scheme 3). As shown in Schemes 2 and 3, toluene under reflux conditions proved to be the most effective solvent compared to other organic solvents such as CH3CN, CH2Cl2, and THF (Table 1, entries 7–9, 11, and 13).


image file: d4ob01004c-s3.tif
Scheme 3 Azomethine ylide generation through oxidative coupling path and C–C/C–N coupling reaction.

Under the optimized conditions established for the smooth decarboxylative formation of azomethine ylide via an organocatalytic pathway (Scheme 2), we also observed the simultaneous grafting of this intermediate with another molecule of β-nitro styrene (3). The resulting [3 + 2] cycloaddition reaction yielded 1-nitro-2,3-diaryl-hexahydro-pyrrolizines (6), as shown in Scheme 4. Because of the high electron deficiency of β-nitro styrene, other common electrophiles did not participate in the [3 + 2] cycloaddition with the in situ generated azomethine ylide. However, when we used maleimide (a very good Michael acceptor), we observed a mixture of products in very poor yield, possibly due to the formation of a Michael adduct between maleimide and L-proline. To investigate the general feasibility of this organocatalytic process, we employed differently substituted β-nitro styrenes while keeping the proline part constant. As expected, methyl (6b, 6h), alkoxy (6c, 6d), halogen (6e, 6f–g), and naphthyl (6i) functionalities were well tolerated under the developed reaction conditions, along with the unsubstituted variety (6a). Using piperidine-2-carboxylic acid instead of L-proline also produced the corresponding octahydro-indolizine derivative (6j). Since azomethine ylide is an achiral and planar intermediate, racemized products (6a–j) were obtained with L-proline. Good yields (60–70%) and a moderate reaction time (8h) have been observed for this developed reaction. Finally, the regio- and stereoselectivity of compound 6g were established based on previous literature and NOESY spectra (ESI).


image file: d4ob01004c-s4.tif
Scheme 4 List of the synthesized hexahydro-pyrrolizines via [3 + 2]-cycloaddition of the azomethine ylide.

By switching to the concept of organocatalysis and introducing benzylamines as components for azomethine ylide development in the presence of an oxidant (Scheme 3), the substrate scope for trapping the azomethine ylide has been expanded. The decarboxylative C–N and Csp3–Csp coupling reactions showcased the versatility of this method in the presence of CuBr (5 mol%) and aerobic conditions, as shown in Scheme 5. Various benzylamines and alkynes were employed under the optimized conditions. The results indicate successful reactions with unsubstituted benzylamines (7a–c, 7h, and 7i) as well as those substituted with electron-withdrawing groups such as nitro (7d and 7k), chloro (7f), and fluoro (7e, 7g, and 7j). In terms of aromatic alkynes, the reaction proceeded well with unsubstituted varieties (7a, 7d, and 7e), as well as those with methyl substituents (7b, 7f, and 7g) and methoxy groups (7c and 7h–k). Additionally, the reaction showed success with substrates containing biphenyl rings (7i) and naphthyl moieties (7h–k). The corresponding 1-benzyl-2-arylethynyl-pyrrolidine derivatives (7a–k) along with 1-(4-methoxybenzyl)-2-(phenylethynyl)piperidine (7l) were obtained in moderate to good yields (53–63%) within a reasonable time frame of 9–12 h. However, it should be noted that the use of electronically activated benzylamines bearing an electron-donating group did not yield the desired product 7.


image file: d4ob01004c-s5.tif
Scheme 5 Synthesis of N-benzyl-2-arylethynylpyrrolidines.

Electron-rich aromatic nuclei underwent C–C coupling with Cu-chelated alkynes to form fused polynuclear-N-heterocycles with an exocyclic double bond (8, Scheme 6) under prolonged heating. Therefore, L-proline (1a), 4-methylbenzylamine (2e), and various terminal alkynes (4) led to the synthesis of the corresponding products 8a–c in good yields (50–60%). Furthermore, naphthylbenzylamine also afforded product 8d in 55% yield following the same protocol. It is worth noting that the choice of different alkynes does not pose any barriers to obtaining the cyclized product 8. All synthesized products were characterized using relevant spectroscopic analyses (ESI).


image file: d4ob01004c-s6.tif
Scheme 6 Extended ring annulation via a C–C coupling reaction.

To trap the intermediate, a three-component coupling reaction was conducted using an electron-deficient olefin, leading to the formation of substituted hexahydro-pyrrolo[3,4-a]pyrrolizine-1,3-diones (9) and hexahydro-pyrrolizines (10a–c) (Scheme 7). Piperidine-2-carboxylic acid also smoothly formed the azomethine ylide, yielding a subsequent cycloadduct (10d and e) with maleimide derivatives. The reaction involved 1,3-dipolar cycloaddition of azomethine ylide intermediates derived from L-proline and benzyl amines, with N-substituted maleimide, fumarate, and cinnamate. The synthesized products (9a–j and 10a–d) were characterized using spectroscopic analyses, and the structures of 9a and 10e were confirmed via a single crystal XRD study.17 Lower yields were attributed to the formation of Michael adducts between benzyl amines and maleimides.


image file: d4ob01004c-s7.tif
Scheme 7 Trapping of azomethine ylides with electron-deficient olefins using 1,3-dipolar cycloaddition reaction.

Possible mechanistic pathways for the developed reaction procedures have been proposed based on literature reports18 and present observations (Scheme 8). The organocatalytic pathway involves L-proline (1a) undergoing Michael addition with β-nitrostyrene (3), followed by amine-catalyzed decarboxylation and elimination of CH3NO2 leading to the formation of the azomethine ylide intermediate I (eqn (iii), Scheme 1). Another pathway involves the Cu-catalysed aerobic oxidation of benzyl amine into an imine19 followed by coupling with L-proline (1a), which then undergoes smooth decarboxylation and liberates ammonia to yield the desired intermediate-I (eqn (iv), Scheme 1). Mass analysis was performed by taking aliquots from the reaction mixture from time to time to identify probable intermediate(s) towards azomethine ylide formation in both pathways (Schemes 2 and 3). To our delight, we observed peaks that corresponded to the probable intermediates, as shown in the ESI. Here, Cu(I) is used to catalyse the oxidation of the amine under aerial O2[thin space (1/6-em)]19 and does not play any further role in azomethine ylide formation or the subsequent 1,3-dipolar cycloaddition reaction. The reaction shown in Scheme 3 stops under a N2 atmosphere.


image file: d4ob01004c-s8.tif
Scheme 8 Possible mechanistic pathways.

Various dienophiles, such as β-nitrostyrene (3, Scheme 4), N-substituted maleimide (5a–j), fumarate ester (5k, and 5l), and trans-ethylcinnamate (5m), as shown in Scheme 7, undergo formal 1,3-dipolar cycloaddition with trans-azomethine dipole (I) via endo-TS to synthesize diverse N-heterocycles (6 and 9–10).18,20 Theoretical DFT calculations show that the regio-isomer reported here (6) is found to be more stable than other possibilities and the endo-TS (6a: 3.074 kcal mol−1 or 0.0049 Hartree; 9a: 3.419 kcal mol−1 or 0.005448 Hartree) is more favourable than the exo-TS (6a: 7.145 kcal mol−1 or 0.011387 Hartree; 9a: 6.203 kcal mol−1 or 0.009885 Hartree). When a terminal alkyne is employed, the azomethine ylide accepts a proton at the benzylic carbon atom and is converted to a simple quaternary imine. Then, nucleophilic addition of Ar2–C[triple bond, length as m-dash]C–Cu species onto the imine takes place to afford the C–C-coupled product 7 (Scheme 5).

All density functional theory (DFT) calculations of this study were performed using the Gaussian 16 program suite with Grimme d3 dispersion correction.21–23 DFT calculations were performed by considering the model structures of the transition states (TS) for exo, endo (Schemes 4 and 7), and regio products, as shown in Scheme 4. To compare the favorable pathway of the reaction, activation energy was calculated considering the electronic structures of the TS.27 Ground state geometry optimizations for all the reactants, products, and intermediates were performed with the B3LYP functional using the localized 6-31g(d,p) basis set. Previous studies reveal that the dispersion corrected B3LYP level of theory offers precise geometry with satisfactory results for this type of mechanism.28 Solvation was introduced implicitly by applying the Polarizable Continuum Model (PCM),29,30 using the integral equation formalism variant as implemented in the Gaussian 16 package with toluene as the solvent. In the solution phase, all geometry optimizations were carried out without symmetry restrictions. Thermodynamic parameters like free energy and enthalpy corrections were evaluated at 298.15 K and 1 atm pressure, incorporating zero point energy corrections (ZPE). Vibration frequency calculation at the same level of theory confirmed that the optimized geometries correspond to minima on the potential energy surfaces. Conformational analysis was done by varying the dihedral angle and finding the minimum energy structure. For the TS calculation, the QST3 method was applied and TS structures were confirmed by imaginary frequency analysis.24 Chem3D 16.0 software was used to calculate the steric energies of different TS geometries through MM2 server computations.25

Following significant experimental observations we have performed density functional theory (DFT) calculations to establish the favorable pathway between exo and endo products. The free energy profile for the exo and endo product 6a shown in Scheme 4 is represented in Fig. 1. The optimized geometries of the reactant, product, and corresponding transition states considering both exo and endo pathways are also shown in the same figure. As per the DFT calculations shown in Scheme 4, a higher free energy barrier via a transition state was observed for the exo product (7 kcal mol−1) than for the endo product (3 kcal mol−1). Due to the low free energy barrier via the endo pathway, endo products are predominantly obtained experimentally.


image file: d4ob01004c-f1.tif
Fig. 1 Computed free energy profiles of 6a, as shown in Scheme 4, for: (a) the endo-isomer and (b) the exo-isomer.

It is well known that typical π–π stacking geometries are known to be energetically favorable.31,32 Fig. 2 shows the electronic structures of TS considering different possible pathways of the reaction shown in Scheme 4. The low energy barrier for the formation of the endo product comes from the stability of the TS through π–π stacking. Two phenyl rings are 3.9 Å apart from each other in the endo TS whereas they are 4.7 Å apart in the exo TS.33 The ‘CH–O’ distance in the endo product is less than that in the exo product (Fig. 2). The presence of secondary orbital interaction in the endo TS is also reflected in the endo TS orbital interaction shown in Fig. 2.26 Regio product formation is very difficult as two phenyl rings are in opposite directions in the TS of this pathway (Fig. 2), revealing the least chance of π–π stacking. Considering all the observations, the endo product should be the predominant product, as shown in Scheme 4.34


image file: d4ob01004c-f2.tif
Fig. 2 TS for different possible pathways of 6a, as shown in Scheme 4.

The same level of theory was used in Scheme 7 (Fig. 3) to identify favorable pathways like the previous one. Free energy calculation reflected that a comparatively stable transition state was obtained for the endo pathway than the exo pathway of product 9a. A lower free energy barrier of 3 kcal mol−1 through the endo pathway than the exo pathway (6 kcal mol−1) is the main reason for the predominant formation of the endo product. As per the MM2 calculation data from Chem3D software, both the endo-TS shown in Schemes 4 and 7 are sterically more stable than the exo-TS considering different energy parameters.25


image file: d4ob01004c-f3.tif
Fig. 3 Computed free energy profiles of 9a, as shown in Scheme 7, for: (a) the endo-isomer and (b) the exo-isomer.

MM2 server computation:

endo-TS (Scheme 4) — stretch energy: 0.9 kcal mol−1; bend energy: 13 kcal mol−1; stretch bend energy: 0.03 kcal mol−1; torsion energy: −12.24 kcal mol−1; non-1,4 VDW energy: −6.04 kcal mol−1; 1,4 VDW energy: 16.89 kcal mol−1; charge dipole–energy: −3.08 kcal mol−1; dipole–dipole energy: −3.85 kcal mol−1; and total energy: 5.61 kcal mol−1.

exo-TS (Scheme 4) — stretch energy: 0.9 kcal mol−1; bend energy: 13.35 kcal mol−1; stretch bend energy: 0.04 kcal mol−1; torsion energy: −11.7 kcal mol−1; non-1,4 VDW energy: −5.78 kcal mol−1; 1,4 VDW energy: 17.03 kcal mol−1; charge dipole–energy: −3 kcal mol−1; dipole–dipole energy: −3.85 kcal mol−1; and total energy: 6.98 kcal mol−1.

endo-TS (Scheme 7) — stretch energy: 2.72 kcal mol−1; bend energy: 32.04 kcal mol−1; stretch bend energy: −0.03 kcal mol−1; torsion energy: −6.0 kcal mol−1; non-1,4 VDW energy: −0.07 kcal mol−1; 1,4 VDW energy: 18.24 kcal mol−1; charge–dipole energy: −15.27 kcal mol−1; dipole–dipole energy: −2.85 kcal mol−1; and total energy: 28.76 kcal mol−1.

exo-TS (Scheme 7) — stretch energy: 2.72 kcal mol−1; bend energy: 32.04 kcal mol−1; stretch bend energy: −0.025 kcal mol−1; torsion energy: −6.16 kcal mol−1; non-1,4 VDW energy: 0.45 kcal mol−1; 1,4 VDW energy: 18.24 kcal mol−1; charge–dipole energy: −15.38 kcal mol−1; dipole–dipole energy: −2.93 kcal mol−1; and total energy: 29.06 kcal mol−1.

Conclusion

Two new methods have been developed for synthesizing azomethine ylide intermediates from L-proline, offering alternatives to conventional techniques. The first method involves organocatalysis, where L-proline reacts with β-nitrostyrene, followed by a 1,3-dipolar cycloaddition reaction. The second method uses a benzyl amine, which undergoes catalytic oxidation under aerobic conditions and reacts with L-proline, allowing for C–C coupling with aromatic alkynes, ring annulations, and [3 + 2]-cycloadditions with suitable olefins. These methods demonstrate good regio- and stereoselectivity, as supported by DFT studies that show slow and symmetry-controlled transition states. Mass spectrometric analysis was used to identify the reaction intermediates and to propose the mechanism for azomethine ylide formation. These methods contribute to the synthesis of valuable N-heterocycles combined with diverse C–N/C–C coupling and cyclization reactions.

Experimental section

Materials and methods

All reagents were purchased from commercial suppliers and used without further purification unless otherwise specified. Commercially supplied ethyl acetate and petroleum ether were distilled before use. The petroleum ether used in our experiments had a boiling range of 60–80 °C. Column chromatography was performed on silica gel (60–120 mesh, 0.12–0.25 mm). Analytical thin-layer chromatography was performed on 0.25 mm extra-hard silica gel plates with a UV 254 fluorescent indicator. The reported melting points are uncorrected. 1H NMR and 13C NMR spectra were recorded at ambient temperature using 300 and 400 MHz spectrometers. Chemical shifts are reported in ppm from the tetramethylsilane internal reference, and coupling constants are reported in Hz. Proton multiplicities are represented as s (singlet), d (doublet), dd (double doublet), t (triplet), q (quartet), and m (multiplet). Infrared spectra were recorded on an FT-IR spectrometer in thin films. HR-MS data were acquired by electron spray ionization on a Q-ToF-micro quadruple mass spectrometer. Optical rotation of the chiral compounds was measured on a polarimeter using a standard 10 cm quartz cell in a sodium-D lamp at ambient temperature.

General procedure for the synthesis of hexahydro-pyrrolizines (6a–i)

L-Proline (1, 1.0 mmol) and β-nitrostyrene (3, 2.2 mmol) were taken in a dry 25 mL RB flask and 10 mL dry toluene was poured into it. Then a very small amount (10 mol%) of benzyl amine (2a) was added and allowed to reflux under stirring conditions. The progress of the reaction was monitored by thin-layer chromatography (TLC). Toluene was removed from the post-reaction mixture through suction at low pressure and high temperature. It was extracted with ethyl acetate (2 × 10 mL). The combined organic layer was washed with water (3 × 10 mL) and brine (1 × 10 mL). It was then dried over anhydrous Na2SO4, filtered, and evaporated using a rotary evaporator under reduced pressure at room temperature. Purification by column chromatography on silica gel (60–120 mesh) with ethyl acetate–hexane (v/v = 1[thin space (1/6-em)]:[thin space (1/6-em)]19) as the eluent afforded the corresponding hexahydro-pyrrolizines 6a–f. All the synthesized compounds were fully characterized using appropriate spectral analyses.

Characterization data of the synthesized hexahydro-1H-pyrrolizines (6a–j)

1-Nitro-2,3-diphenylhexahydro-1H-pyrrolizine (6a). Compound 6a was prepared using trans-β-nitrostyrene and L-proline as starting materials to give the product as a brown sticky liquid; yield: 68% (210 mg); 1H NMR (300 MHz, CDCl3): δ 7.40–7.15 (m, 10H), 5.05–4.98 (m, 1H), 4.34 (d, J = 9.3 Hz, 1H), 3.84–3.82 (m, 1H), 3.66–3.59 (m, 1H), 2.91–2.87 (m, 1H), 2.77–2.74 (m, 1H), 2.11–1.80 (m, 4H); 13C NMR (75 MHz, CDCl3): δ 138.8, 136.8, 129.0 (2C), 128.8 (2C), 128.6, 128.0, 127.3 (2C), 127.1 (2C), 97.9, 73.7, 69.9, 56.9, 53.8, 31.8, 25.1; FT-IR (neat, cm−1): 2924, 1723, 1602, 1550, 1495, 1455, 1368; HR-MS (m/z) for C19H21N2O2 (M + H)+: calculated 309.1603, found 309.1600.
1-Nitro-2,3-dip-tolylhexahydro-1H-pyrrolizine (6b). Compound 6b was prepared using trans-4-methyl-β-nitrostyrene and L-proline as starting materials to give the product as a deep brown sticky oil; yield: 70% (235 mg); 1H NMR (300 MHz, CDCl3): δ 7.33 (d, J = 8.1 Hz, 2H), 7.18–7.13 (m, 6H), 5.08–5.01 (m, 1H), 4.35 (d, J = 9.3 Hz, 1H), 3.95–3.93 (m, 1H), 3.65–3.59 (m, 1H), 3.00–2.94 (m, 1H), 2.84–2.80 (m, 1H), 2.33 (s, 3H), 2.31 (s, 3H), 2.16–1.84 (m, 4H); 13C NMR (75 MHz, CDCl3): δ 139.0, 138.1, 134.0, 133.2, 129.9, 129.8, 129.7, 129.6, 128.9, 127.4, 127.4, 127.2, 97.0, 73.6, 70.0, 56.4, 53.8, 31.6, 25.0, 21.2, 21.1; FT-IR (neat, cm−1): 1724, 1600, 1557, 1490, 1366; HR-MS (m/z) for C21H25N2O2 (M + H)+: calculated 337.1916, found 337.1918.
2,3-Bis(4-ethoxyphenyl)-1-nitrohexahydro-1H-pyrrolizine (6c). Compound 6c was prepared using trans-4-methoxy-β-nitrostyrene and L-proline as starting materials to give the product as a brown sticky liquid; yield: 64% (236 mg); 1H NMR (300 MHz, CDCl3): δ 7.36–7.19 (m, 4H), 6.90–6.88 (m, 4H), 4.97 (t, J = 10.5 Hz, 1H), 4.29 (d, J = 9.3 Hz, 1H), 3.84–3.70 (m, 7H), 3.63–3.56 (m, 1H), 2.90–2.88 (m, 1H), 2.80–2.78 (m, 1H), 2.04–1.70 (m, 4H); 13C NMR (75 MHz, CDCl3): δ 159.9, 159.4, 128.8 (2C), 128.5 (2C), 128.3 (2C), 114.5 (2C), 114.2 (2C), 98.0, 73.3, 69.7, 58.3, 55.3 (2C), 57.8, 31.9, 25.0; FT-IR (neat, cm−1): 1727, 1605, 1564, 1559, 1494, 1369; HR-MS (m/z) for C21H25N2O4 (M + H)+: calculated 369.1814, found 369.1818.
2,3-Bis(4-(benzyloxy)phenyl)-1-nitrohexahydro-1H-pyrrolizine (6d). Compound 6d was prepared using 4-benzyloxy-trans-β-nitrostyrene and L-proline as starting materials to give the product as a brown viscous oil; yield: 60% (312 mg); 1H NMR (300 MHz, CDCl3): δ 7.41–7.21 (m, 14H), 6.99–6.87 (m, 4H), 5.09–5.04 (m, 5H), 4.36 (d, J = 9.3 Hz, 1H), 4.09–4.01 (m, 1H), 3.62 (t, J = 9.9 Hz, 1H), 3.01–2.99 (m, 1H), 2.88–2.85 (m, 1H), 2.07–1.84 (m, 4H); 13C NMR (75 MHz, CDCl3): δ 159.2, 158.6, 136.8, 136.8, 128.8 (2C), 128.6 (2C), 128.5 (2C), 128.4 (2C), 128.0 (2C), 127.5 (2C), 127.4 (2C), 115.4 (2C), 115.2 (2C), 97.6, 73.3 (2C), 70.0 (2C), 69.8 (2C), 56.2, 53.9, 31.8, 24.9; FT-IR (neat, cm−1): 1728, 1601, 1557, 1491, 1452, 1366; HR-MS (m/z) for C33H33N2O4 (M + H)+: calculated 521.2440, found 521.2443.
2,3-Bis(4-bromophenyl)-1-nitrohexahydro-1H-pyrrolizine (6e). Compound 6e was prepared using trans-4-bromo-β-nitrostyrene and L-proline as starting materials to give the product as a brown sticky oil; yield: 65% (303 mg); 1H NMR (300 MHz, CDCl3): δ 7.52–7.47 (m, 4H), 7.34–7.31 (m, 2H), 7.16 (dd, J = 6.6, 1.8 Hz, 2H), 4.98–4.91 (m, 1H), 4.35 (d, J = 9 Hz, 1H), 3.82–3.79 (m, 1H), 3.68–3.62 (m, 1H), 2.98–2.95 (m, 1H), 2.78–2.75 (m, 1H), 2.10–1.84 (m, 4H); 13C NMR (75 MHz, CDCl3): δ 137.9, 135.7, 132.2 (2C), 131.9 (2C), 128.9 (2C), 128.6 (2C), 122.4, 122.0, 97.5, 72.8, 69.7, 56.2, 53.7, 31.7, 25.1; FT-IR (neat, cm−1): 1729, 1602, 1557, 1493, 1367; HR-MS (m/z) for C19H19Br2N2O2 (M + H)+: calculated 464.9813, found 464.9811 (one of the major peaks).
2,3-Bis(4-chlorophenyl)-1-nitrohexahydro-1H-pyrrolizine (6f). Compound 6f was prepared using trans-4-chloro-β-nitrostyrene and L-proline as starting materials to give the product as a deep yellow viscous oil; yield: 60% (226 mg); 1H NMR (300 MHz, CDCl3): δ 7.41–7.15 (m, 8H), 4.94–4.88 (m, 1H), 4.35 (d, J = 9 Hz, 1H), 3.79–3.75 (m, 1H), 3.68–3.62 (m, 1H), 2.96–2.91 (m, 1H), 2.76–2.71 (m, 1H), 2.10–1.80 (m, 4H); 13C NMR (75 MHz, CDCl3): δ 137.7, 135.4, 134.4, 134.0, 129.3 (2C), 129.0 (2C), 128.7 (2C), 128.3 (2C), 97.9, 72.9, 69.8, 56.3, 53.8, 31.8, 25.2; FT-IR (neat, cm−1): 1721, 1602, 1555, 1457, 1360, 1267; HR-MS (m/z) for C19H19Cl2N2O2 (M + H)+: calculated 377.0824, found 377.0819 (one of the major peaks).
2,3-Bis(4-fluorophenyl)-1-nitrohexahydro-1H-pyrrolizine (6g). Compound 6g was prepared using trans-4-fluoro-β-nitrostyrene and L-proline as starting materials to give the product as a light yellow semisolid; yield: 62% (213 mg); 1H NMR (300 MHz, CDCl3): δ 7.44–7.34 (m, 2H), 7.28–7.24 (m, 2H), 7.09–7.02 (m, 4H), 4.96–4.89 (m, 1H), 4.36 (d, J = 9.3 Hz, 1H), 3.83–3.77 (m, 1H), 3.70–3.64 (m, 1H), 2.98–2.92 (m, 1H), 2.80–2.75 (m, 1H), 2.10–2.02 (m, 2H), 1.95–1.82 (m, 2H); 13C NMR (75 MHz, CDCl3): δ 164.5, 164.1, 161.2, 160.8, 134.8, 132.7 (2C), 129.0, 128.8, 128.6, 128.5, 116.2, 115.9, 115.8, 115.6, 98.2, 72.9, 69.8, 56.2, 53.7, 31.9, 25.2; 19F NMR (400 MHz, CDCl3): δ −115.90 to −113.40 (multiple peaks); FT-IR (neat, cm−1): 1720, 1605, 1552, 1458, 1361, 1264; HR-MS (m/z) for C19H19F2N2O2 (M + H)+: calculated 345.1415, found 345.1411.
2,3-Bis(2,5-dimethylphenyl)-1-nitrohexahydro-1H-pyrrolizine (6h). Compound 6h was prepared using (E)-1,4-dimethyl-2-(2-nitrovinyl)benzene and L-proline as starting materials to give the product as a yellow semisolid; yield: 64% (232 mg); 1H NMR (300 MHz, CDCl3): δ 7.56 (s, 1H), 7.23 (s, 1H), 7.08–6.98 (m, 4H), 5.14–5.08 (m, 1H), 4.75 (d, J = 9 Hz, 1H), 4.20–4.13 (m, 1H), 3.88–3.83 (m, 1H), 2.96–2.90 (m, 1H), 2.85–2.79 (m, 1H), 2.40 (s, 3H), 2.35 (s, 6H), 2.29 (s, 3H), 2.26–2.12 (m, 2H), 1.94–1.88 (m, 2H); 13C NMR (75 MHz, CDCl3): δ 136.8, 136.2, 136.0, 135.7, 133.4, 133.3, 130.7, 130.6, 128.8, 128.2, 128.0, 127.1, 96.6, 71.3, 69.9, 53.7, 52.2, 32.1, 25.1, 21.1, 21.1, 19.2, 18.7; FT-IR (neat, cm−1): 1727, 1600, 1558, 1488, 1363; HR-MS (m/z) for C23H28N2NaO2 (M + Na)+: calculated 387.2048, found 387.2045.
2,3-Di(naphthalen-1-yl)-1-nitrohexahydro-1H-pyrrolizine (6i). Compound 6i was prepared using (E)-1-(2-nitrovinyl)naphthalene and L-proline as starting materials to give the product as a brown sticky oil; yield: 55% (224 mg); 1H NMR (300 MHz, CDCl3): δ 8.35–8.29 (m, 2H), 8.04 (d, J = 6.9 Hz, 1H), 7.94–7.81 (m, 4H), 7.65–7.48 (m, 7H), 5.64–5.57 (m, 1H), 5.42 (d, J = 8.7 Hz, 1H), 4.84–4.79 (m, 1H), 4.21–4.15 (m, 1H), 3.10–2.97 (m, 2H), 2.32–2.25 (m, 1H), 2.19–2.08 (m, 2H), 2.01–1.95 (m, 1H); 13C NMR (75 MHz, CDCl3): δ 134.8, 134.2, 134.1, 133.9, 131.7, 129.2, 129.1 (2C), 128.5, 126.7, 126.5, 126.0, 125.9 (2C), 125.7, 125.6 (2C), 125.0, 122.6, 122.5, 99.0, 71.6, 70.9, 53.7, 53.2, 32.4, 25.4; FT-IR (neat, cm−1): 1731, 1607, 1550, 1492, 1370; HR-MS (m/z) for C27H25N2O2 (M + H)+: calculated 409.1916, found 409.1913.
2,3-Bis(4-bromophenyl)-1-nitrooctahydroindolizine (6j). Compound 6j was prepared using trans-4-bromo-β-nitrostyrene and DL-pipecolinic acid as starting materials to give the product as a brown sticky liquid; yield: 62% (296.36 mg); 1H NMR (300 MHz, CDCl3): δ 7.23–7.29 (m, 5H), 6.79–6.84 (m, 3H), 5.11 (t, J = 8.1 Hz, 1H), 4.86 (d, J = 9 Hz, 1H), 4.66 (d, J = 8.4 Hz, 1H), 3.66–3.72 (m, 4H), 2.87 (d, J = 13.8 Hz, 1H), 2.37–2.52 (m, 2H), 1.95 (d, J = 11.1 Hz, 2H); 13C NMR (75 MHz, CDCl3): δ 136.1, 132.6, 131.4 (2C), 131.1 (2C), 130.4 (2C), 130.1 (2C), 121.2, 121.0, 100.0, 66.6, 61.2, 50.0, 46.7, 29.7, 23.6, 20.9; FT-IR (neat, cm−1): 2924, 1723, 1602, 1550, 1495, 1455, 1368; HR-MS (m/z) for C20H21Br2N2O2 (M + H)+: calculated 478.9970, found 478.9974 (one of the major peaks).

General procedure for the synthesis of n-benzyl-2-arylethynyl-pyrrolidines/piperidine (7a–l) and extended ring annulations (8a–d)

L-Proline (1, 1.0 mmol) and aliphatic amine (2, 1.2 mmol) were added to a 25 mL RB flask containing 10 mL dry toluene and allowed to reflux for 30 min at 130 °C in the presence of a catalytic amount (5 mol%) of CuBr. Terminal alkyne 4 (1 mmol) was added to the reaction mixture under hot conditions and heating was continued with stirring. The progress of the reaction was monitored by thin-layer chromatography (TLC). We observed the formation of several spots during heating. Under prolonged heating (∼24 h), some of these spots transformed into another new spot. The post-reaction mixture was filtered through a Celite bed in the sintered funnel and the solvent was removed. Then the crude product was extracted with EtOAc (2 × 10 mL). The combined organic layer was washed with water (3 × 10 mL) and brine (1 × 10 mL). It was then dried over anhydrous Na2SO4, filtered, and evaporated using a rotary evaporator under reduced pressure at room temperature. Purification by column chromatography on silica gel (60–120 mesh) with ethyl acetate–hexane (v/v = 1[thin space (1/6-em)]:[thin space (1/6-em)]9) as an eluent afforded the corresponding N-benzyl-2-arylethynyl-pyrrolidines/piperdines (7a–l) and hexahydropyrrolo[1,2-b]isoquinolines (8a–d). All the synthesized compounds were fully characterized using relevant spectral analyses.

Characterization data of the synthesized n-benzyl-2-arylethynyl-pyrrolidines/piperidines (7a–l) and extended ring annulations (8a–d)

1-Benzyl-2-(phenylethynyl)pyrrolidine (7a)35. Compound 7a was prepared using benzylamine, phenylacetylene and L-proline as starting materials to give the product as a yellow oil; yield: 53% (138 mg); 1H NMR (300 MHz, CDCl3): δ 7.49–7.39 (m, 4H), 7.35–7.25 (m, 6H), 4.8 (dd, J = 12.9, 3.3 Hz, 1H), 3.68–3.62 (m, 2H), 2.82–2.79 (m, 1H), 2.61–2.58 (m, 1H), 2.19–2.16 (m, 1H), 2.06–1.83 (m, 3H); 13C NMR (75 MHz, CDCl3): δ 138.3, 131.7, 129.3 (2C), 128.2 (2C), 128.0 (4C), 127.0, 122.9, 88.8, 84.9, 57.0, 54.5, 51.4, 31.6, 21.9; FT-IR (neat, cm−1): 1901, 1678, 1600, 1506, 1500, 1444; HR-MS (m/z) for C19H19NNa (M + Na)+: calculated 284.1415, found 284.1412.
1-Benzyl-2-(p-tolylethynyl)pyrrolidine (7b). Compound 7b was prepared using benzylamine, 4-ethynyltoluene and L-proline as starting materials to give the product as a brown viscous liquid; yield: 50% (138 mg); 1H NMR (300 MHz, CDCl3): δ 7.51–7.29 (m, 7H), 7.18 (d, J = 7.8 Hz, 2H), 4.13 (d, J = 12.9 Hz, 1H), 3.85–3.73 (m, 2H), 2.92–2.87 (m, 1H), 2.79–2.74 (m, 1H), 2.37 (s, 3H), 2.37–2.25 (m, 1H), 2.17–1.91 (m, 3H); 13C NMR (75 MHz, CDCl3): δ 137.3, 133.4, 131.8 (2C), 126.6, 129.5, 129.1 (2C), 128.3 (2C), 127.4, 122.8, 86.9, 86.0, 56.4, 54.7, 51.3, 31.5, 21.8, 21.1; FT-IR (neat, cm−1): 2926, 1900, 1689, 1606, 1492, 1447; HR-MS (m/z) for C20H22N (M + H)+: calculated 276.1752, found 276.1748.
1-Benzyl-2-((4-methoxyphenyl)ethynyl)pyrrolidine (7c). Compound 7c was prepared using benzylamine, 4-ethynylanisole and L-proline as starting materials to give the product as a deep yellow sticky liquid; yield: 63% (183 mg); 1H NMR (300 MHz, CDCl3): δ 7.48–7.24 (m, 7H), 6.85 (d, J = 8.7 Hz, 2H), 4.10 (d, J = 12.9 Hz, 1H), 3.81 (s, 3H), 3.69–3.64 (m, 2H), 2.83–2.79 (m, 1H), 2.63–2.56 (m, 1H), 2.20–1.82 (m, 4H); 13C NMR (75 MHz, CDCl3): δ 159.4, 137.9, 133.1 (2C), 129.4, 128.2 (2C), 127.2, 115.3, 114.1, 113.9, 113.9, 86.4, 85.3, 57.0, 55.3, 54.6, 51.4, 31.6, 21.9; FT-IR (neat, cm−1): 2925, 1908, 1683, 1604, 1509, 1493, 1454; HR-MS (m/z) for C20H22NO (M + H)+: calculated 292.1701, found 292.1704.
1-(4-Nitrobenzyl)-2-(phenylethynyl)pyrrolidine (7d). Compound 7d was prepared using 4-nitrobenzylamine, phenylacetylene and L-proline as starting materials to give the product as a red sticky liquid; yield: 62% (190 mg); 1H NMR (300 MHz, CDCl3): δ 8.18 (d, J = 8.4 Hz, 2H), 7.57 (d, J = 8.1, 2H), 7.45–7.41 (m, 2H), 7.33–7.30 (m, 3H), 4.11 (d, J = 13.6 Hz, 1H), 3.73 (d, J = 13.8 Hz, 1H), 3.67–3.63 (m, 1H), 2.79–2.76 (m, 1H), 2.61–2.57 (m, 1H), 2.20–2.17 (m, 1H), 2.09–1.85 (m, 3H); 13C NMR (75 MHz, CDCl3): δ 147.1, 146.7, 131.6 (2C), 129.6 (2C), 128.6, 128.2, 128.1, 123.4 (2C), 123.0, 87.9, 85.4, 56.5, 54.6, 51.7, 31.7, 22.1; FT-IR (neat, cm−1): 2923, 1904, 1672, 1665, 1508, 1494, 1384; HR-MS (m/z) for C19H19N2O2 (M + H)+: calculated 307.1447, found 307.1451.
1-(4-Fluorobenzyl)-2-(phenylethynyl)pyrrolidine (7e). Compound 7e was prepared using 4-fluorobenzylamine, phenylacetylene and L-proline as starting materials to furnish the product as an orange viscous liquid; yield: 55% (153 mg); 1H NMR (300 MHz, CDCl3): δ 7.49–7.30 (m, 7H), 7.04–6.98 (m, 2H), 4.08–4.02 (m, 1H), 3.66–3.60 (m, 2H), 2.80–2.77 (m, 1H), 2.64–2.58 (m, 1H), 2.01–1.84 (m, 4H); 13C NMR (75 MHz, CDCl3): δ 163.65, 160.40, 133.8, 131.7 (2C), 130.8, 130.7, 129.4, 128.2 (2C), 128.1, 127.3, 123.1, 115.14, 114.86, 87.9, 85.4, 56.2, 54.4, 51.4, 31.5, 21.9; 19F NMR (400 MHz, CDCl3): δ −113.07 to −107.33 (multiple peaks); FT-IR (neat, cm−1): 1904, 1680, 1604, 1507, 1499, 1439; HR-MS (m/z) for C19H19FN (M + H)+: calculated 280.1502, found 280.1507.
1-(4-Chlorobenzyl)-2-(p-tolylethynyl)pyrrolidine (7f). Compound 7f was prepared using 4-chlorobenzylamine, 4-ethynyltoluene and L-proline as starting materials to give the product as a deep brown oil; yield: 60% (186 mg); 1H NMR (300 MHz, CDCl3): δ 7.29–7.19 (m, 6H), 7.06 (d, J = 8.4 Hz, 2H), 3.96 (d, J = 12.9 Hz, 1H), 3.56–3.52 (m, 2H), 2.75–2.67 (m, 1H), 2.54–2.47 (m, 1H), 2.29 (s, 3H), 2.16–1.75 (m, 4H); 13C NMR (75 MHz, CDCl3): δ 138.2, 137.0, 132.8, 131.6 (2C), 130.6 (2C), 129.0 (2C), 128.4 (2C), 120.1, 87.3, 85.5, 56.4, 54.6, 51.5, 31.7, 22.0, 21.5; FT-IR (neat, cm−1): 2921, 1903, 1682, 1605, 1509, 1490, 1444; HR-MS (m/z) for C20H21ClN (M + H)+: calculated 310.1363, found 310.1365 (one of the major peaks).
1-(4-Fluorobenzyl)-2-(p-tolylethynyl)pyrrolidine (7g). Compound 7g was prepared using 4-fluorobenzylamine, 4-ethynyltoluene and L-proline as starting materials to give the product as a brown sticky oil; yield: 56% (164 mg); 1H NMR (300 MHz, CDCl3): δ 7.43–7.34 (m, 4H), 7.15–7.12 (m, 3H), 7.01 (t, J = 8.4 Hz, 1H), 4.05 (d, J = 12.9 Hz, 1H), 3.67–3.63 (m, 2H), 2.81–2.78 (m, 1H), 2.63–2.61 (m, 1H), 2.36 (s, 3H), 2.21–1.85 (m, 4H); 13C NMR (75 MHz, CDCl3): δ 163.68, 160.43, 139.4, 138.2, 133.6, 132.3, 131.6 (2C), 130.9, 130.8, 129.2, 129.0 (2C), 115.16, 114.88, 86.9, 85.7, 57.2, 56.1, 54.5, 31.4, 21.9, 21.2; FT-IR (neat, cm−1): 2923, 1907, 1675, 1605, 1508, 1492, 1443; HR-MS (m/z) for C20H21FN (M + H)+: calculated 294.1658, found 294.1661.
1-Benzyl-2-((6-methoxynaphthalen-2-yl)ethynyl)pyrrolidine (7h). Compound 7h was prepared using benzylamine, 2-ethynyl-6-methoxynaphthalene and L-proline as starting materials to give the product as a yellow semisolid; yield: 60% (205 mg); 1H NMR (300 MHz, CDCl3): δ 7.91 (s, 1H), 7.71–7.66 (m, 2H), 7.50–7.45 (m, 3H), 7.37–7.28 (m. 3H), 7.18–7.11 (m, 2H), 4.14 (d, J = 12.9 Hz, 1H), 3.93 (s, 3H), 3.76–3.72 (m, 2H), 2.87–2.83 (m, 1H), 2.70–2.66 (m, 1H), 2.25–2.22 (m, 1H), 2.14–1.87 (m, 3H); 13C NMR (75 MHz, CDCl3): δ 158.2, 138.0, 134.0, 131.3, 129.4 (2C), 129.2 (2C), 128.4, 128.3 (2C), 127.3, 126.7, 119.3, 118.0, 105.8, 87.5, 86.2, 57.0, 55.3, 54.0, 51.4, 31.6, 22.0; FT-IR (neat, cm−1): 2921, 1903, 1682, 1605, 1509, 1490, 1444; HR-MS (m/z) for C24H24NO (M + H)+: calculated 342.1858, found 342.1854.
1-Benzyl-2-(biphenyl-4-ylethynyl)pyrrolidine (7i). Compound 7i was prepared using benzylamine, 4-ethynylbiphenyl and L-proline as starting materials to give the product as a brown viscous liquid; yield: 62% (209 mg); 1H NMR (300 MHz, CDCl3): δ 7.54–7.44 (m, 6H), 7.40–7.18 (m, 8H), 4.03 (d, J = 12.9 Hz, 1H), 3.66–3.61 (m, 2H), 2.80–2.73 (m, 1H), 2.60–2.57 (m, 1H), 2.15–2.12 (m, 1H), 2.03–1.78 (m, 3H); 13C NMR (75 MHz, CDCl3): δ 140.8, 140.4, 137.7, 132.1 (2C), 129.4 (2C), 128.8 (2C), 128.3 (2C), 127.6, 127.2 (2C), 127.0, 126.9, 122.0 (2C), 88.5, 85.4, 56.9, 54.5, 51.4, 31.5, 21.9; FT-IR (neat, cm−1): 2931, 1904, 1680, 1603, 1500, 1491, 1440; HR-MS (m/z) for C25H24N (M + H)+: calculated 338.1909, found 338.1907.
1-(4-Fluorobenzyl)-2-{(6-methoxynaphthalen-2-yl)ethynyl}pyrrolidine (7j). Compound 7j was prepared using 4-fluorobenzylamine, 2-ethynyl-6-methoxynaphthalene and L-proline as starting materials to give the product as a brown sticky oil; yield: 62% (223 mg); 1H NMR (300 MHz, CDCl3): δ 7.89 (s, 1H), 7.71–7.66 (m, 2H), 7.48–7.38 (m, 3H), 7.18–6.98 (m. 4H), 4.07 (d, J = 12.9 Hz, 1H), 3.93 (s, 3H), 3.70–3.66 (m, 2H), 2.83–2.80 (m, 1H), 2.70–2.62 (m, 1H), 2.23–1.97 (m, 4H); 13C NMR (75 MHz, CDCl3): δ 163.7, 160.6, 158.9, 134.1, 133.7, 131.3, 131.0, 130.9, 129.2 (2C), 128.5, 126.8 (2C), 119.4 (2C), 118.0, 115.2, 114.9, 105.9, 56.2, 55.3, 54.6, 51.4, 31.7, 22.0; FT-IR (neat, cm−1): 1904, 1743, 1686, 1600, 1514, 1487, 1429; HR-MS (m/z) for C24H23FNO (M + H)+: calculated 360.1764, found 360.1768.
2-((6-Methoxynaphthalen-2-yl)ethynyl)-1-(4-nitrobenzyl)pyrrolidine (7k). Compound 7k was prepared using 4-nitrobenzylamine, 2-ethynyl-6-methoxynaphthalene and L-proline as starting materials to give the product as a red viscous liquid; yield: 63% (243 mg); 1H NMR (300 MHz, CDCl3): 8.19 (d, J = 8.7 Hz, 2H), 8.17 (s, 1H), 7.70–7.66 (m, 2H), 7.59 (d, J = 8.7 Hz, 2H), 7.44 (dd, J = 8.4, 1.5 Hz, 1H), 7.18–7.10 (m, 2H), 4.15 (d, J = 13.8 Hz, 1H), 3.93 (s, 3H), 3.75 (d, J = 13.8 Hz, 1H), 3.69–3.65 (m, 1H), 2.82–2.79 (m, 1H), 2.61–2.57 (m, 1H), 2.23–1.87 (m, 4H); 13C NMR (75 MHz, CDCl3): δ 158.2, 147.0, 134.0, 131.2, 129.5 (2C), 129.1 (3C), 128.4, 126.7, 123.4 (2C), 119.4, 117.9, 105.8, 87.6, 85.7, 56.6, 55.3, 54.8, 51.8, 31.8, 22.2; FT-IR (neat, cm−1): 2926, 1903, 1685, 1603, 1507, 1499, 1441; HR-MS (m/z) for C24H23N2O3 (M + H)+: calculated 387.1709, found 387.1711.
1-(4-Methoxybenzyl)-2-(phenylethynyl)piperidine (7l). Compound 7l was prepared using 4-methoxy benzylamine, phenylacetylene and DL-pipecolinic acid as starting materials to give the product as a yellow oil; yield: 60% (183.25 mg); 1H NMR (300 MHz, CDCl3): δ 7.50–7.53 (m, 2H), 7.32–7.36 (m, 5H), 6.88 (d, J = 8.7 Hz, 2H), 3.82 (s, 3H), 3.71 (s, 1H), 3.65 (d, J = 7.5 Hz, 2H), 2.55–2.64 (m, 2H), 1.82–1.85 (m, 3H), 1.58–1.63 (m, 3H); 13C NMR (75 MHz, CDCl3): δ 158.7, 131.8 (3C), 130.5 (2C), 128.3 (2C), 127.9, 123.6, 113.6 (2C), 87.5, 86.8, 59.9, 56.2, 51.4, 49.2, 31.3, 25.8, 20.9; FT-IR (neat, cm−1): 1901, 1678, 1600, 1506, 1500, 1444; HR-MS (m/z) for C21H24NO (M + H)+: calculated 306.1858, found 306.1854.
(Z)-10-(4-Methoxybenzylidene)-8-methyl-1,2,3,5,10,10a-hexahydropyrrolo[1,2-b]isoquinoline (8a). Compound 8a was prepared using 4-methylbenzylamine, 4-ethynylanisole and L-proline as starting materials to give the product as a brown sticky liquid; yield: 60% (183 mg); 1H NMR (300 MHz, CDCl3): δ 7.47–7.32 (m, 4H), 7.16 (d, J = 7.8 Hz, 2H), 6.86 (d, J = 9 Hz, 2H), 4.12 (d, J = 12.9 Hz, 1H), 3.89–3.82 (m, 5H), 2.93–2.86 (m, 2H), 2.56–2.34 (m, 4H), 2.17–1.96 (m, 3H); 13C NMR (75 MHz, CDCl3): δ 159.7, 137.5, 134.0, 133.2, 133.1 (2C), 129.8, 129.6, 129.1, 114.7, 114.01, 114.0, 113.9 (2C), 56.2, 55.3, 54.9, 51.1, 31.5, 21.7, 21.1; FT-IR (neat, cm−1): 3431, 2927, 1618, 1567, 1513, 1451; HR-MS (m/z) for C21H24NO (M + H)+: calculated 306.1858, found 306.1853.
(Z)-10-Benzylidene-8-methyl-1,2,3,5,10,10a-hexahydropyrrolo[1,2-b]isoquinoline (8b). Compound 8b was prepared using 4-methylbenzylamine, phenylacetylene and L-proline as starting materials to give the product as a brown sticky liquid; yield: 50% (138 mg); 1H NMR (300 MHz, CDCl3): δ 7.50 (d, J = 6.6 Hz, 2H), 7.39–7.25 (m, 5H), 7.15 (d, J = 8.1 Hz, 2H), 4.16 (d, J = 12.9 Hz, 1H), 3.83 (d, J = 12.9 Hz, 2H), 2.92–2.81 (m, 2H), 2.42–2.31 (m, 4H), 2.18–1.93 (m, 3H); 13C NMR (75 MHz, CDCl3): δ 138.7, 131.7 (4C), 129.9, 129.1, 128.8 (4C), 128.5, 127.9, 119.4, 56.5, 55.1, 51.3, 31.5, 21.8, 21.5; FT-IR (neat, cm−1): 3437, 2923, 1619, 1568, 1510, 1454; HR-MS (m/z) for C20H22N (M + H)+: calculated 276.1752, found 276.1749.
(Z)-10-(Biphenyl-4-ylmethylene)-8-methyl-1,2,3,5,10,10a-hexahydropyrrolo[1,2-b]isoquinoline (8c). Compound 8c was prepared using 4-methylbenzylamine, 4-ethynylbiphenyl and L-proline as starting materials to give the product as a brown sticky liquid; yield: 58% (204 mg); 1H NMR (300 MHz, CDCl3): δ 7.53–7.18 (m, 11H), 7.08 (d, J = 7.8 Hz, 2H), 4.01 (d, J = 12.9 Hz, 1H), 3.68 (d, J = 12.9 Hz, 2H), 2.81–2.76 (m, 1H), 2.67–2.57 (m, 1H), 2.33–2.17 (m, 4H), 2.10–1.81 (m, 3H); 13C NMR (75 MHz, CDCl3): δ 141.0, 140.3, 137.2, 132.1 (3C), 129.6 (2C), 129.0 (3C), 128.8 (3C), 128.3, 127.6, 127.0 (3C), 127.8, 56.4, 54.6, 51.2, 31.5, 21.8, 21.1; FT-IR (neat, cm−1): 3436, 2929, 1616, 1568, 1517, 1457; HR-MS (m/z) for C26H26N (M + H)+: calculated 352.2065, found 352.2069.
(Z)-7-Benzylidene-7,7a,8,9,10,12-hexahydrobenzo[h]pyrrolo[1,2-b]isoquinoline (8d). Compound 8d was prepared using 1-naphthylmethylamine, phenylacetylene and L-proline as starting materials to give the product as a brown sticky liquid; yield: 55% (171 mg); 1H NMR (300 MHz, CDCl3): δ 8.42–8.39 (m, 1H), 7.88–7.80 (m, 2H), 7.64–7.34 (m, 9H), 4.71 (d, J = 12.9 Hz, 1H), 4.06 (d, J = 13.5 Hz, 1H), 3.88–3.70 (m, 1H), 2.93–2.88 (m, 1H), 2.68–2.63 (m, 1H), 2.27–1.84 (m, 4H); 13C NMR (75 MHz, CDCl3): δ 133.8, 133.4, 132.5, 131.9, 131.8, 131.7 (2C), 128.5, 128.3 (2C), 128.2, 127.8, 126.1, 122.7, 125.3, 124.5, 123.0, 55.4, 54.6, 51.7, 31.6, 29.7, 22.0; FT-IR (neat, cm−1): 2928, 1618, 1567, 1512, 1455; HR-MS (m/z) for C23H22N (M + H)+: calculated 312.1752, found 312.1755.

General procedure for the synthesis of hexahydropyrrolo[3,4-a]pyrrolizine-1,3-diones (9a–j) and hexahydropyrrolizines (10a–c) and octahydropyrrolo[3,4-a]indolizine-1,3(2H)-dione (10d)

Proline (1, 1.0 mmol) and aliphatic amine (2, 1.2 mmol) were added to a 25 mL RB flask containing 10 mL dry toluene and allowed to reflux for 30 min at 130 °C in the presence of a catalytic amount (5 mol%) of CuBr. The electron-deficient alkene 5 (1 mmol) was added to the reaction mixture under hot conditions and heating was continued with stirring. The progress of the reaction was monitored by thin layer chromatography (TLC). The post-reaction mixture was filtered through a Celite bed in the sintered funnel and the solvent was removed. Then the crude product was extracted with EtOAc (2 × 10 mL). The combined organic layer was washed with water (3 × 10 mL) and brine (1 × 10 mL). It was then dried over anhydrous Na2SO4, filtered, and evaporated using a rotary evaporator under reduced pressure at room temperature. Purification by column chromatography on silica gel (60–120 mesh) with ethyl acetate–hexane (v/v = 1[thin space (1/6-em)]:[thin space (1/6-em)]9) as the eluent afforded the corresponding hexahydro-pyrrolo[3,4-a]pyrrolizine-1,3-diones (9a–j) and hexahydro-pyrrolizines (10a–c) and octahydropyrrolo[3,4-a]indolizine-1,3(2H)-dione (10d). All the synthesized compounds were fully characterized using appropriate spectral analyses. The structure of 9a was confirmed using single crystal XRD analyses.

Characterization data of the synthesized hexahydro-pyrrolo[3,4-a]pyrrolizine-1,3-diones (9a–j) and hexahydro-pyrrolizines (10a–c) and octahydropyrrolo[3,4-a]indolizine-1,3(2H)-dione (10d–e)

2-Methyl-4-phenylhexahydropyrrolo[3,4-a]pyrrolizine-1,3(2H,8bH)-dione (9a). Compound 9a was prepared using benzylamine, N-methylmaleimide and L-proline as starting materials to give the product as a pale brown solid; yield: 40% (108 mg); m.p. 122–124 °C; 1H NMR (300 MHz, CDCl3): δ 7.51–7.26 (m, 5H), 4.22 (d, J = 6 Hz, 1H), 3.96–3.94 (m, 1H), 3.62 (t, J = 8.4 Hz, 1H), 3.42–3.37 (m, 1H), 3.06–3.0 (m, 4H), 2.69–2.66 (m, 1H), 2.06–1.83 (m, 4H); 13C NMR (75 MHz, CDCl3): δ 178.0, 177.1, 141.6, 128.6 (2C), 127.6, 127.0 (2C), 69.6, 66.2, 55.4, 51.8, 47.9, 26.6, 24.9, 24.3; FT-IR (KBr, cm−1): 3473, 2919, 2869, 1703, 1386; HR-MS (m/z) for C16H19N2O2 (M + H)+: calculated 271.1447, found 271.1451.
4-(4-Fluorophenyl)-2-methylhexahydropyrrolo[3,4-a]pyrrolizine-1,3(2H,8bH)-dione (9b). Compound 9b was prepared using 4-fluorobenzylamine, N-methylmaleimide and L-proline as starting materials to give the product as a pale brown sticky liquid; yield: 45% (130 mg); 1H NMR (300 MHz, CDCl3): δ 7.48–7.44 (m, 2H), 7.07–7.01 (m, 2H), 4.03–3.91 (m, 2H), 3.63 (t, J = 9 Hz, 1H), 3.36–3.31 (m, 1H), 3.01–2.94 (m, 4H), 2.65–2.60 (m, 1H), 2.05–1.59 (m, 4H); 13C NMR (75 MHz, CDCl3): δ 177.7, 176.8, 163.9, 160.7, 136.9, 128.8, 128.7, 115.6, 115.4, 69.0, 66.2, 55.4, 51.6, 47.6, 26.7, 24.9, 24.3; 19F NMR (400 MHz, CDCl3): δ −115.28 to −115.33 (one multiplate); FT-IR (neat, cm−1): 3474, 2918, 2866, 1702, 1384; HR-MS (m/z) for C16H18FN2O2 (M + H)+: calculated 289.1352, found 289.1354.
2-Methyl-4-p-tolylhexahydropyrrolo[3,4-a]pyrrolizine-1,3(2H,8bH)-dione (9c). Compound 9c was prepared using 4-methylbenzylamine, N-methylmaleimide and L-proline as starting materials to give the product as a light brown sticky oil; yield: 44% (125 mg); 1H NMR (300 MHz, CDCl3): δ 7.44 (d, J = 7.2 Hz, 2H), 7.24 (d, J = 7.8 Hz, 2H), 4.11–4.02 (m, 2H), 3.72 (t, J = 9.3 Hz, 1H), 3.51–3.46 (m, 1H), 3.10–3.05 (m, 4H), 2.75–2.43 (m, 1H), 2.33 (s, 3H), 2.16–1.67 (m, 4H); 13C NMR (75 MHz, CDCl3): δ 177.6, 176.8, 137.7, 137.5, 129.5 (2C), 127.1 (2C), 69.6, 66.3, 55.2, 51.4, 47.7, 26.6, 25.0, 24.3, 21.1; FT-IR (neat, cm−1): 3476, 2920, 2870, 1703, 1388; HR-MS (m/z) for C17H21N2O2 (M + H)+: calculated 285.1603, found 285.1601.
4-(4-Chlorophenyl)-2-methylhexahydropyrrolo[3,4-a]pyrrolizine-1,3(2H,8bH)-dione (9d). Compound 9d was prepared using 4-chlorobenzylamine, N-methylmaleimide and L-proline as starting materials to give the product as a brown sticky oil; yield: 40% (122 mg); 1H NMR (300 MHz, CDCl3): δ 7.46–7.32 (m, 4H), 4.03 (d, J = 6.3 Hz, 1H), 3.90 (q, J = 7.2 Hz, 1H), 3.60 (t, J = 9 Hz, 1H), 3.56–3.30 (m, 1H), 3.03–2.95 (m, 4H), 2.66–2.17 (m, 1H), 2.05–1.57 (m, 4H); 13C NMR (75 MHz, CDCl3): δ 177.8, 176.9, 140.3, 133.3, 128.8 (2C), 128.4 (2C), 69.0, 66.2, 55.4, 51.8, 47.7, 26.7, 24.9, 24.4; FT-IR (neat, cm−1): 3475, 2917, 2865, 1708, 1388; HR-MS (m/z) for C16H18ClN2O2 (M + H)+: calculated 305.1057, found 305.1053 (one of the major peaks).
4-(4-Chlorophenyl)-2-phenylhexahydropyrrolo[3,4-a]pyrrolizine-1,3(2H,8bH)-dione (9e)6. Compound 9e was prepared using 4-chlorobenzylamine, N-phenylmaleimide and L-proline as starting materials to give the product as a red sticky liquid; yield: 42% (154 mg); 1H NMR (300 MHz, CDCl3): δ 7.52–7.25 (m, 9H), 4.25 (d, J = 6 Hz, 1H), 4.10–4.02 (m, 1H), 3.76 (t, J = 9 Hz, 1H), 3.53–3.48 (m, 1H), 3.10–3.08 (m, 1H), 2.75–2.71 (m, 1H), 2.17–1.82 (m, 4H); 13C NMR (75 MHz, CDCl3): δ 176.7, 175.8, 140.0, 133.5, 131.7, 129.4 (2C), 129.2, 128.8, 128.7, 128.4, 126.2 (2C), 122.0, 66.6, 66.8, 55.3, 52.0, 47.7, 26.6, 24.5; FT-IR (neat, cm−1): 3473, 2918, 2869, 1703, 1385; HR-MS (m/z) for C21H20ClN2O2 (M + H)+: calculated 367.1213, found 367.1208 (one of the major peaks).
4-(4-Fluorophenyl)-2-phenylhexahydropyrrolo[3,4-a]pyrrolizine-1,3(2H,8bH)-dione (9f). Compound 9f was prepared using 4-fluorobenzylamine, N-phenylmaleimide and L-proline as starting materials to give the product as a brown sticky liquid; yield: 39% (137 mg); 1H NMR (300 MHz, CDCl3): δ 7.55–7.40 (m, 5H), 7.32–7.27 (m, 2H), 7.08 (t, J = 8.7 Hz, 2H), 4.26 (d, J = 6 Hz, 1H), 4.14–4.05 (m, 1H), 3.80 (t, J = 9 Hz, 1H), 3.57–3.52 (m, 1H), 3.13–3.06 (m, 1H), 2.78–2.73 (m, 1H), 2.17–1.86 (m, 4H); 13C NMR (75 MHz, CDCl3): δ 176.7, 175.8, 164.0, 160.7, 136.8, 131.7, 129.2 (2C), 129.0, 128.8, 128.7, 128.7, 126.2 (2C), 115.7, 115.4, 69.5, 66.7, 55.3, 51.8, 47.6, 26.5, 24.4; FT-IR (neat, cm−1): 3472, 2919, 2868, 1704, 1387; HR-MS (m/z) for C21H19FN2NaO2 (M + Na)+: calculated 373.1328, found 373.1324.
2-Benzyl-4-p-tolylhexahydropyrrolo[3,4-a]pyrrolizine-1,3(2H,8bH)-dione (9g). Compound 9g was prepared using 4-methylbenzylamine, N-benzylmaleimide and L-proline as starting materials to give the product as a light brown oil; yield: 40% (144 mg); 1H NMR (300 MHz, CDCl3): δ 7.42–7.08 (m, 9H), 4.64 (s, 2H), 4.06–3.65 (m, 2H), 3.62 (t, J = 9.3 Hz, 1H), 3.56–3.44 (m, 1H), 3.00–2.96 (m, 1H), 2.54–2.48 (m, 1H), 2.34 (s, 3H), 1.76–1.57 (m, 4H); 13C NMR (75 MHz, CDCl3): δ 177.2, 176.3, 137.7, 135.4, 129.5, 129.0 (2C), 128.7 (2C), 128.5, 128.1, 128.0, 127.1 (2C), 69.8, 66.5, 55.2, 51.6, 47.7, 42.6, 26.1, 24.2, 21.1; FT-IR (neat, cm−1): 3471, 2913, 2868, 1703, 1384; HR-MS (m/z) for C23H25N2O2 (M + H)+: calculated 361.1916, found 361.1918.
2-Benzyl-4-phenylhexahydropyrrolo[3,4-a]pyrrolizine-1,3(2H,8bH)-dione (9h). Compound 9h was prepared using benzylamine, N-benzylmaleimide and L-proline as starting materials to give the product as a brown viscous liquid; yield: 38% (132 mg); 1H NMR (300 MHz, CDCl3): δ 7.47–7.26 (m, 10H), 4.65 (s, 2H), 4.15–4.08 (m, 1H), 4.10–3.91 (m, 1H), 3.56 (t, J = 9 Hz, 1H), 3.42–3.37 (m, 1H), 2.94–2.92 (m, 1H), 2.46–2.43 (m, 1H), 2.12–1.55 (m, 4H); 13C NMR (75 MHz, CDCl3): δ 177.7, 176.7, 141.8, 135.4, 129.0 (2C), 128.6 (4C), 128.0, 127.4, 126.8 (2C), 69.6, 66.4, 55.5, 52.0, 48.0, 42.5, 26.1, 24.2; FT-IR (neat, cm−1): 3473, 2922, 2869, 1703, 1657, 1382; HR-MS (m/z) for C22H23N2O2 (M + H)+: calculated 347.1760, found 347.1757.
2-Benzyl-4-(4-fluorophenyl)hexahydropyrrolo[3,4-a]pyrrolizine-1,3(2H,8bH)-dione (9i). Compound 9i was prepared using 4-fluorobenzylamine, N-benzylmaleimide and L-proline as starting materials to give the product as a light brown oil; yield: 37% (135 mg); 1H NMR (300 MHz, CDCl3): δ 7.46–7.26 (m, 7H), 7.03 (t, J = 8.7 Hz, 2H), 4.65 (s, 2H), 4.05 (d, J = 6 Hz, 1H), 3.90–3.81 (m, 1H), 3.56 (t, J = 9 Hz, 1H), 3.36–3.29 (m, 1H), 2.94–2.87 (m, 1H), 2.84–2.40 (m, 1H), 2.05–1.49 (m, 4H); 13C NMR (75 MHz, CDCl3): δ 177.5, 176.4, 163.8, 160.6, 137.2, 135.4, 129.0 (2C), 128.6 (2C), 128.5, 128.2, 128.1, 115.5, 115.3, 69.0, 66.3, 55.4, 51.7, 47.7, 42.5, 26.2, 24.3; FT-IR (neat, cm−1): 3470, 2919, 2867, 1735, 1703, 1387; HR-MS (m/z) for C22H21FN2NaO2 (M + Na)+: calculated 387.1485, found 387.1489.
2-Benzyl-4-(4-chlorophenyl)hexahydropyrrolo[3,4-a]pyrrolizine-1,3(2H,8bH)-dione (9j). Compound 9j was prepared using 4-chlorobenzylamine, N-benzylmaleimide and L-proline as starting materials to give the product as a brown sticky liquid; yield: 40% (152 mg); 1H NMR (300 MHz, CDCl3): δ 7.54–7.23 (m, 9H), 4.74 (s, 2H), 4.31 (d, J = 6.6 Hz, 1H), 4.12–4.07 (m, 1H), 3.87 (t, J = 9 Hz, 1H), 3.66–3.61 (m, 1H), 3.20–3.10 (m, 1H), 2.90–2.70 (m, 1H), 2.24–1.89 (m, 4H); 13C NMR (75 MHz, CDCl3): δ 175.9, 175.0, 134.2, 131.5, 129.5, 129.2 (2C), 129.1, 128.9 (2C), 128.8, 126.2 (2C), 122.4, 69.9, 67.2, 54.9, 51.9, 47.3, 43.8, 26.5, 24.5; FT-IR (neat, cm−1): 3478, 2915, 2863, 1702, 1386; HR-MS (m/z) for C22H22ClN2O2 (M + H)+: calculated 381.1370, found 381.1367 (one of the major peaks).
Diethyl-3-(4-fluorophenyl)hexahydro-1H-pyrrolizine-1,2-dicarboxylate (10a). Compound 10a was prepared using 4-fluorobenzylamine, diethyl fumarate and L-proline as starting materials to give the product as an orange oil; yield: 37% (129 mg); 1H NMR (300 MHz, CDCl3): δ 7.36–7.25 (m, 2H), 7.00–6.95 (m, 2H), 4.18–3.99 (m, 2H), 3.88–3.82 (m, 2H), 3.31–3.24 (m, 1H), 3.10–3.03 (m, 1H), 2.81–2.77 (m, 1H), 2.61–2.57 (m, 1H), 2.05–1.77 (m, 4H), 2.23 (t, J = 7.2 Hz, 3H), 1.07 (t, J = 7.2 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 171.8, 171.7, 163.1, 160.8, 137.0, 128.8, 128.7, 115.2, 144.9, 72.5, 66.9, 60.8, 60.7, 57.2, 53.5, 53.2, 32.1, 25.1, 14.0, 13.9; FT-IR (neat, cm−1): 2958, 1735, 1609, 1507, 1439; HR-MS (m/z) for C19H25FNO4 (M + H)+: calculated 350.1768, found 350.1772.
Dimethyl-3-(4-fluorophenyl)hexahydro-1H-pyrrolizine-1,2-dicarboxylate (10b). Compound 10b was prepared using 4-fluorobenzylamine, dimethyl maleate and L-proline as starting materials to give the product as a yellow oil; yield: 35% (112 mg); 1H NMR (300 MHz, CDCl3): δ 7.49–7.44 (m, 2H), 7.07–7.01 (m, 2H), 3.91–3.87 (m, 1H), 3.72–3.65 (m, 4H), 3.57 (s, 3H), 3.38–3.31 (m, 1H), 3.14–3.07 (m, 1H), 2.84–2.80 (m, 1H), 2.64–2.59 (m, 1H), 2.06–1.81 (m, 4H); 13C NMR (75 MHz, CDCl3): δ 172.0, 163.9, 160.7, 136.2, 128.9, 128.8, 115.0, 114.9, 72.5, 67.0, 56.8, 53.3, 53.1, 52.1, 51.9, 32.0, 25.0; FT-IR (neat, cm−1): 2954, 1733, 1606, 1509, 1438; HR-MS (m/z) for C17H21FNO4 (M + H)+: calculated 322.1455, found 322.1451.
Ethyl-2,3-diphenylhexahydro-1H-pyrrolizine-1-carboxylate (10c). Compound 10c was prepared using benzylamine, ethyl cinnamate and L-proline as starting materials to give the product as a red oil; yield: 35% (117 mg); 1H NMR (300 MHz, CDCl3): δ 7.56–7.25 (m, 10H), 4.18–4.15 (m, 2H), 3.89 (q, J = 3.6 Hz, 2H), 3.45–3.26 (m, 2H), 3.06–3.02 (m, 1H), 2.90–2.86 (m, 1H), 2.48–1.83 (m, 4H), 0.86 (t, J = 7.2 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 171.2, 138.3, 135.7, 129.8, 129.4, 129.1, 128.1, 128.7, 128.6, 127.9, 127.7 (2C), 127.5, 125.7, 77.2, 74.3, 72.0, 59.5, 56.0, 53.3, 31.0, 24.9, 13.8; FT-IR (neat, cm−1): 2954, 1734, 1606, 1508, 1436; HR-MS (m/z) for C22H26NO2 (M + H)+: calculated 336.1964, found 336.1961.
4-(4-Bromophenyl)-2-methyloctahydro-1H-pyrrolo[3,4-a]indolizine-1,3(2H)-dione (10d). Compound 10d was prepared using 4-bromobenzylamine, N-methylmaleimide and DL-pipecolinic acid as starting materials to give the product as a white solid; yield: 40% (144.8 mg); 1H NMR (300 MHz, CDCl3): δ 7.48–7.51 (m, 2H), 6.98–7.00 (m, 2H), 4.53 (s, 1H), 3.43 (d, J = 8.1 Hz, 1H), 3.34 (d, J = 1.2 Hz, 1H), 3.32 (s, 3H), 2.88–3.31 (m, 1H), 2.73–2.79 (m, 2H), 1.97–2.02 (m, 1H), 1.58–1.76 (m, 2H), 1.39–1.44 (m, 2H), 1.01–1.14 (m, 1H); 13C NMR (75 MHz, CDCl3): δ 178.6, 176.6, 135.7, 131.4 (2C), 130.1 (2C), 121.9, 68.1, 59.4, 50.0, 48.4, 48.2, 28.5, 25.1, 24.5, 24.00; FT-IR (neat, cm−1): 3475, 2917, 2865, 1708, 1388; HR-MS (m/z) for C17H20BrN2O2 (M + H)+: calculated 363.0708, found 363.0705 (one of the major peaks).
4-(4-Fluorophenyl)-2-(p-tolyl)octahydro-1H-pyrrolo[3,4-a]indolizine-1,3(2H)-dione (10e). Compound 10e was prepared using 4-fluorobenzylamine, N-para-tolylmaleimide and DL-pipecolinic acid as starting materials to give the product as a white solid; yield: 70% (145 mg); 1H NMR (300 MHz, CDCl3): δ 7.30 (d, J = 8.1 Hz, 2H), 7.20–7.23 (m, 2H), 7.08–7.14 (m, 4H), 4.70 (s, 1H), 3.60 (t, J = 8.1 Hz, 1H), 3.48–3.51 (m, 1H), 2.83–2.88 (m, 2H), 2.41 (s, 3H), 2.04–2.09 (m, 1H), 1.64–1.80 (m, 2H), 1.45–1.50 (m, 2H), 1.28 (s, 2H); 13C NMR (75 MHz, CDCl3): δ 21.1, 23.9, 24.5, 28.6, 29.5, 48.2, 50.1, 59.5, 68.3, 115.1, 126.3, 129.4, 129.6, 129.9, 132.3, 138.5, 162.2, 175.8, 177.8; 19F NMR (400 MHz, CDCl3): δ −114.36 (one singlet); FT-IR (neat, cm−1): 3475, 2917, 2865, 1708, 1388; HR-MS (m/z) for C23H24FN2O2 (M + H)+: calculated 379.1822, found 379.1826.

Data availability

All data associated with the research in this manuscript are findable, accessible, interoperable, and reusable.

Conflicts of interest

The authors have no conflict of interest.

Acknowledgements

The research fellowship provided by UGC (SA) and funding from the Ministry of Mines (Met4-14/19/2021), GOI are gratefully acknowledged.

Notes and references

  1. (a) J. Adrio and J. C. Carretero, Recent advances in the catalytic asymmetric 1,3-dipolar cycloaddition of azomethine ylides, Chem. Commun., 2014, 50, 12434 RSC ; (b) A. Padwa and W. H. Pearson, Synthetic Applications of 1,3-Dipolar Cycloaddition Chemistry Toward Heterocycles and Natural Products, Wiley, Chichester, U.K., 2002, vol. 59, p. 940 CrossRef ; (c) I. Coldham and R. Hufton, Intramolecular dipolar cycloaddition reactions of azomethine ylides, Chem. Rev., 2005, 105, 2765 CrossRef CAS PubMed ; (d) G. Pandey, P. Banerjee and S. R. Gadre, Construction of enantiopure pyrrolidine ring system via asymmetric [3 + 2]-cycloaddition of azomethine ylides, Chem. Rev., 2006, 106, 4484 CrossRef CAS PubMed ; (e) T. M. V. D. Pinho e Melo, Conjugated Azomethine Ylides, Eur. J. Org. Chem., 2006, 2873 CrossRef CAS ; (f) X. Fang and C.-J. Wang, Catalytic asymmetric construction of spiropyrrolidines via 1,3-dipolar cycloaddition of azomethine ylides, Org. Biomol. Chem., 2018, 16, 2591 RSC ; (g) R. Narayan, M. Potowski, Z.-J. Jia, A. P. Antonchick and H. Waldmann, Catalytic enantioselective 1,3-dipolar cycloadditions of azomethine ylides for biology-oriented synthesis, Acc. Chem. Res., 2014, 47(4), 1296 CrossRef CAS PubMed .
  2. (a) B. Bdiri, B.-J. Zhao and Z.-M. Zhou, Recent advances in the enantioselective 1,3-dipolar cycloaddition of azomethine ylides and dipolarophiles, Tetrahedron: Asymmetry, 2017, 28(7), 876 CrossRef CAS ; (b) F. Shi, S.-W. Luo, Z.-L. Tao, L. He, J. Yu, S.-J. Tu and L.-Z. Gong, The catalytic asymmetric 1,3-dipolar cycloaddition of ynones with azomethine ylides, Org. Lett., 2011, 13(17), 4680 CrossRef CAS PubMed ; (c) C. Nejera and J. M. Sansano, Asymmetric 1,3-dipolar cycloadditons of stabilized azomethine ylides with nitroalkenes, Curr. Top. Med. Chem., 2014, 14(10), 1271 CrossRef CAS PubMed ; (d) P. Allway and R. Grigg, Chiral Co(II) and Mn(II) catalysts for the 1,3-dipolar cycloaddition reactions of azomethine ylides derived from arylidene imines of glycine, Tetrahedron Lett., 1991, 32(41), 5817 CrossRef CAS ; (e) L.-Z. Gong, X.-H. Chen, Q. Wei, S.-W. Luo and H. Xiao, Organocatalytic synthesis of spiro[pyrrolidin-3,3′-oxindoles] with high enantiopurity and structural diversity, J. Am. Chem. Soc., 2009, 131(38), 13819 CrossRef PubMed .
  3. I. Narberhaus, U. Papke, C. Theuring, T. Beuerle, T. Hartmann and S. Dobler, Direct Evidence for Membrane Transport of Host-Plant-Derived Pyrrolizidine Alkaloid N-Oxides in Two Leaf Beetle Genera, J. Chem. Ecol., 2004, 30, 2003 CrossRef CAS PubMed .
  4. P. Gupta, P. Garg and N. Roy, In silico screening for identification of novel HIV-1 integrase inhibitors using QSAR and docking methodologies, Med. Chem. Res., 2013, 22, 5014 CrossRef CAS .
  5. S. E. Darwish, Facile synthesis of heterocycles via 2-picolinium bromide and antimicrobial activities of the products, Molecules, 2008, 13, 1066 CrossRef PubMed .
  6. J. Hunter, C. M. Pask and V. Sridharan, Iridium catalyzed three component cycloaddition cascades to fused ring heterocycles, Tetrahedron Lett., 2016, 57, 2774–2777 CrossRef CAS .
  7. (a) L. W. Smith and C. C. J. Culvenor, Plant sources of hepatotoxic pyrrolizidine alkaloids, J. Nat. Prod., 1981, 44, 129 CrossRef CAS PubMed ; (b) M. Kempf, A. Reinhard and T. Beuerle, Pyrrolizidine alkaloids (PAs) in honey and pollen–legal regulation of PA levels in food and animal feed required, Mol. Nutr. Food Res., 2010, 54, 158 CrossRef CAS PubMed ; (c) J. A. Edgar, E. Roeder and R. J. Molyneux, Honey from plants containing pyrrolizidine alkaloids: a potential threat to health, J. Agric. Food Chem., 2002, 50, 2719 CrossRef CAS PubMed .
  8. P. Allway and R. Grigg, Chiral Co(II) and Mn(II) catalysts for the 1,3-dipolar cycloaddition reactions of azomethine ylides derived from arylidene imines of glycine, Tetrahedron Lett., 1991, 32, 5817 CrossRef CAS .
  9. J. M. Longmire, B. Wang and X. Zhang, Highly enantioselective Ag(I)-catalyzed [3 + 2] cycloaddition of azomethine ylides, J. Am. Chem. Soc., 2002, 124, 13400 CrossRef CAS PubMed .
  10. A. S. Gothelf, K. V. Gothelf, R. G. Hazell and K. A. Jørgensen, Catalytic Asymmetric 1,3-Dipolar Cycloaddition Reactions of Azomethine Ylides—A Simple Approach to Optically Active Highly Functionalized Proline Derivatives, Angew. Chem., Int. Ed., 2002, 41, 4236 CrossRef CAS .
  11. G. P. Rizzi, Evidence for an azomethine ylide intermediate in the carbonyl-assisted decarboxylation of sarcosine. Novel synthesis of DL-phenylephrine hydrochloride, J. Org. Chem., 1970, 35, 2069 CrossRef CAS .
  12. (a) T. A. Graf, T. K. Anderson and N. B. Bowden, Extended Lifetimes of Gold(III) Chloride Catalysts using Copper(II) Chloride and 2,2,6,6-Tetramethylpiperidine 1-Oxyl (TEMPO), Adv. Synth. Catal., 2011, 353, 1033 CrossRef CAS ; (b) V. A. Peshkov, O. P. Pereshivko and E. V. Van der Eycken, A walk around the A3-coupling, Chem. Soc. Rev., 2012, 41, 3790 RSC ; (c) N. Gommermann, C. Koradin, K. Polborn and P. Knochel, Enantioselective, Copper(I)-Catalyzed Three Component Reaction for the Preparation of Propargylamines, Angew. Chem., Int. Ed., 2003, 42, 5763 CrossRef CAS .
  13. (a) C. Zhang, C. K. De, R. Mal and D. Seidel, α-Amination of nitrogen heterocycles: Ring-fused aminals, J. Am. Chem. Soc., 2008, 130, 416 CrossRef CAS ; (b) S. Murarka, C. Zhang, M. D. Konieczynska and D. Seidel, Lewis acid catalyzed formation of tetrahydroquinolines via an intramolecular redox process, Org. Lett., 2009, 11, 129 CrossRef CAS PubMed ; (c) C. Zhang and D. Seidel, Nontraditional reactions of azomethine ylides: decarboxylative three-component couplings of α-amino acids, J. Am. Chem. Soc., 2010, 132, 1798 CrossRef CAS PubMed ; (d) I. Deb and D. Seidel, Retro-Claisen condensation versus pyrrole formation in reactions of amines and 1,3-diketones, Tetrahedron Lett., 2010, 51, 2945 CrossRef CAS ; (e) C. Zhang, D. Das and D. Seidel, Azomethine ylide annulations: facile access to polycyclic ring systems, Chem. Sci., 2011, 2, 233 RSC ; (f) I. Deb, D. Das and D. Seidel, Redox Isomerization via Azomethine Ylide Intermediates: N-Alkyl Indoles from Indolines and Aldehydes, Org. Lett., 2011, 13, 812 CrossRef CAS ; (g) M. K. Vecchione, A. X. Sun and D. Seidel, Divergent reactions of indoles with aminobenzaldehydes: indole ring-opening vs. annulation and facile synthesis of neocryptolepine, Chem. Sci., 2011, 2, 2178 RSC ; (h) D. Das, M. T. Richers, L. Ma and D. Seidel, The decarboxylative Strecker reaction, Org. Lett., 2011, 13, 6584 CrossRef CAS PubMed ; (i) L. Ma, W. Chen and D. Seidel, Redox-neutral α-cyanation of amines, J. Am. Chem. Soc., 2012, 134, 15305 CrossRef CAS PubMed .
  14. (a) A. S. K. Hashmi, D. Riedel, M. Rudolph, F. Rominger and T. Oeser, Regioselective formation of saturated abnormal NHC–gold(I) complexes by [3 + 2] cycloaddition of azomethine ylides and isonitrile gold(I) complexes, Chem. – Eur. J., 2012, 18, 3827 CrossRef CAS PubMed ; (b) R. Manzano, F. Rominger and A. S. K. Hashmi, Saturated abnormal NHC–Gold(I) complexes: synthesis and catalytic activity, Organometallics, 2013, 32, 2199 CrossRef CAS ; (c) R. Manzano, T. Wurm, F. Rominger and A. S. K. Hashmi, Room-Temperature Hydrohydrazination of Terminal Alkynes Catalyzed by Saturated Abnormal N-Heterocyclic Carbene–Gold(I) Complexes, Chem. – Eur. J., 2014, 20, 6844 CrossRef CAS PubMed .
  15. S. A. Molla, D. Ghosh, A. Basak, S. Khamarui and D. K. Maiti, Cu(I)-catalysed cross-coupling reaction of in situ generated azomethine ylides towards easy construction of fused N-heterocycles, Chem. Commun., 2023, 59, 4664 RSC .
  16. (a) H.-P. Bi, Q. Teng, M. Guan, W.-W. Chen, Y.-M. Liang, X. Yao and C.-J. Li, Aldehyde- and Ketone-Induced Tandem Decarboxylation-Coupling (Csp3–Csp) of Natural α-Amino Acids and Alkynes, J. Org. Chem., 2010, 75, 783 CrossRef CAS PubMed ; (b) H.-P. Bi, L. Zhao, Y.-M. Liang and C.-J. Li, The Copper-Catalyzed Decarboxylative Coupling of the sp3-Hybridized Carbon Atoms of α-Amino Acids, Angew. Chem., Int. Ed., 2009, 48, 792 CrossRef CAS PubMed ; (c) X. Chang, J.-D. Ran, X.-T. Liu and C.-J. Wang, Catalytic asymmetric benzylation of azomethine ylides enabled by synergistic Lewis acid/palladium catalysis, Org. Lett., 2022, 24, 2573 CrossRef CAS PubMed ; (d) J. Hunter, C. M. Pask and V. Sridharan, Iridium catalyzed three component cycloaddition cascades to fused ring heterocycles, Tetrahedron Lett., 2016, 57, 2774 CrossRef CAS .
  17. CCDC number of compound 9a: 1832647..
  18. V. S. Moshkin, V. Y. Sosnovskikh, P. A. Slepukhin and G.-V. Röschenthaler, 1,3-Dipolar cycloadditions of nonstabilised azomethine ylides at 3-substituted coumarins: Synthesis of 1-benzopyrano[3,4-c]pyrrolidines, Mendeleev Commun., 2012, 22, 29 CrossRef CAS .
  19. (a) Z. Li and C.-J. Li, CuBr-Catalyzed Efficient Alkynylation of sp3 C–H Bonds Adjacent to a Nitrogen Atom, J. Am. Chem. Soc., 2004, 126, 11810 CrossRef CAS PubMed ; (b) M. Largeron, Protocols for the catalytic oxidation of primary amines to imines, Eur. J. Org. Chem., 2013, 5225 CrossRef CAS .
  20. (a) L. Li, X.-M. Chen, Z.-S. Wang, B. Zhou, X. Liu, X. Lu and L.-W. Ye, Reversal of Regioselectivity in Catalytic Arene-Ynamide Cyclization: Direct Synthesis of Valuable Azepino[4,5-b]indoles and β-Carbolines and DFT Calculations, ACS Catal., 2017, 7, 4004 CrossRef CAS ; (b) A. J. Walkinshaw, W. Xu, M. G. Suero and M. J. Gaunt, Copper-catalyzed carboarylation of alkynes via vinyl cations, J. Am. Chem. Soc., 2013, 135, 12532 CrossRef CAS PubMed .
  21. M. Frisch, G. Trucks, H. Schlegel, G. Scuseria, M. Robb, J. Cheeseman, et al., Gaussian 16, Gaussian Inc., Wallingford, CT, 2016 Search PubMed .
  22. S. Tsuzuki and T. Uchimaru, Accuracy of intermolecular interaction energies, particularly those of hetero-atom containing molecules obtained by DFT calculations with Grimme's D2, D3 and D3BJ dispersion corrections, Phys. Chem. Chem. Phys., 2020, 22, 22508–22519 RSC .
  23. T. K. Pati, S. A. Molla, N. N. Ghosh, M. Kundu, S. Ajarul, P. Maity, U. Khamrai and D. K. Maiti, 2-Pyridone-Directed CuII-Catalyzed General Method of C(sp2)-H Activation for C–S, C–Se, and C–N Cross-Coupling: Easy Access to Aryl Thioethers, Selenide Ethers, and Sulfonamides and DFT Study, J. Org. Chem., 2024, 89, 6798–6812 CrossRef CAS PubMed .
  24. G. Zhang, J. Li, B. Long and Z. Liu, Automated reaction mechanisms and kinetics based transition state search process AMK-gau_xtb and its application to the substitution reaction of the nitroso group in 2,4,6-trinitrotoluene by hydroxide anion in the aqueous phase, Phys. Chem. Chem. Phys., 2021, 23, 23673–23683 RSC .
  25. S. Jawla and D. V. Rai, QSAR Descriptors of Rudrakine Molecule of Rudraksha (Elaeocarpus ganitrus) Using Computation Servers, German Journal of Pharmacy and Life Science, 2016, 1(1), 1–16 Search PubMed .
  26. C. S. Wannere, A. Paul, R. Herges, K. N. Houk, H. F. Schaefer III and P. V. R. Schleyer, The existence of secondary orbital interactions, J. Comput. Chem., 2007, 28, 344–361 CrossRef CAS PubMed .
  27. A. Joshi, Z. Iqbal, P. Kandwal and S. Ranjan De, Pd(II)-Catalyzed Non-Directed Benzylic C(sp3)–H Activation: Cascade C(sp3)–S Bond Cleavage to Access Benzaldehydes from BenzylphenylSulfides and Sulfoxides, Asian J. Org. Chem., 2022, 11(12), e202200400 CrossRef CAS .
  28. M. Saeys, M.-F. Reyniers, G. B. Marin, V. V. Speybroeck and M. Waroquier, Ab initio calculations for hydrocarbons: enthalpy of formation, transition state geometry, and activation energy for radical reactions, J. Phys. Chem. A, 2003, 107(43), 9147 CrossRef CAS .
  29. S. Miertuš, E. Scrocco and J. Tomasi, Electrostatic interaction of a solute with a continuum. A direct utilizaion of AB initio molecular potentials for the prevision of solvent effects, Chem. Phys., 1981, 55(1), 117 CrossRef .
  30. M. Cossi, V. Barone, R. Cammi and J. Tomasi, Ab initio study of solvated molecules: a new implementation of the polarizable continuum model, Chem. Phys. Lett., 1996, 255, 327–335 CrossRef CAS .
  31. M. O. Sinnokrot, E. F. Valeev and C. D. Sherrill, Estimates of the ab initio limit for π–π interactions: The benzene dimer, J. Am. Chem. Soc., 2002, 124(36), 10887 CrossRef CAS PubMed .
  32. G. B. McGaughey, M. Gagné and A. K. Rappé, π-stacking interactions: alive and well in proteins, J. Biol. Chem., 1998, 273(25), 15458 CrossRef CAS PubMed .
  33. Y. Liu, A. A. Gallo, Y. Liu, M. B. Hall and B. R. Johnson, QM evaluation of the intramolecular aromatic π-π interactions of Ir(I) complex transition states, J. Mol. Struct., 2023, 1291, 135907 CrossRef CAS .
  34. M. Rubab, M. N. Akhtar, W. Zierkiewicz, M. Michalczyk, R. Nadeem, M. Shahid, M. N. Tahir, M. Akram, Md. A. Hanif and M. A. AlDamen, The role of hydrogen bonding in π⋯π stacking interactions in Ni(II) complex derived from triethanolamine: Synthesis, crystal structure, antimicrobial, and DFT studies, Res. Chem. Intermed., 2019, 45, 5649 CrossRef CAS .
  35. H.-P. Bi, L. Zhao, Y.-M. Liang and C.-J. Li, The Copper-Catalyzed Decarboxylative Coupling of the sp3-Hybridized Carbon Atoms of α-Amino Acids, Angew. Chem., Int. Ed., 2009, 48, 792 CrossRef CAS PubMed .

Footnotes

Electronic supplementary information (ESI) available: Details on synthesis, experimental procedure and additional spectra [NMR, ESI-MS]. CCDC 1832647 and 2312186. For ESI and crystallographic data in CIF or other electronic format see DOI: https://doi.org/10.1039/d4ob01004c
These authors contributed equally.

This journal is © The Royal Society of Chemistry 2024